Lack of skilled manpower to lead and manage the regulatory pharmacovigilance process, and the absence of effective post-marketing surveillance system remains a major gap in Africa. PROFORMA strives to fill this gap by forging partnerships between local academic institutions (training-of-the-trainers for sustainability) and national medicine regulatory authorities (practical training to change policy into practice) by using existing structures in Ethiopia, Kenya, Tanzania, and Rwanda.

The PROFORMA consortium is a joint venture between academia, regulatory authorities, Reginal and Global pharmacovigilance stakeholders from

• Five Medical Universities:
  • Karolinska Institutet, Sweden (Associate Professor Eleni Aklillu, co-ordinator)
  • Collage of Health sciences, Addis Ababa University, Ethiopia
  • School of Pharmacy, University of Nairobi, Kenya
  • School of Pharmacy- Muhimbili University of Health and Allied Sciences (SoP-MUHAS), Tanzania
  • University of Rwanda, Rwanda

• Four National medicine regulatory authorities:
  • Ethiopian Food, Medicine and Health Care Administration and Authority (EFMHACA),
  • Pharmacy and Poisons Board (PPB), Kenya
  • Tanzania Food & Drugs Authority (TFDA), Tanzania
  • Ministry of Health, Rwanda,

• • Two Regional Centre of Regulatory Excellences (RCOREs) in Africa
    • PPB: RCORE in Pharmacovigilance.
    • TFDA and SoP-MUHAS: RCORE in medicine evaluation and registration
  • WHO collaborating centres in Pharmacovigilance Centre-Lareb